Verastem (VSTM) Equity Ratio (2011 - 2026)

Verastem (VSTM) recorded quarterly Equity Ratio of 0.36 in Q1 2026, up 54.67% quarter-over-quarter from 0.23 in Q4 2025, and up 245.77% on a YoY basis from 0.1 in Q1 2025.

Verastem (VSTM) Equity Ratio (2011 - 2026) Analysis & Trends

Verastem's Equity Ratio history runs 16 years deep, the most recent figure standing at 0.36 for Q1 2026.

  • In Q1 2026, Equity Ratio rose 245.77% year-over-year to 0.36; the TTM figure through Mar 2026 stood at 0.36 (up 245.77% YoY), while the FY2025 annual figure was 0.23, up 181.56% from the prior year.
  • Equity Ratio was 0.36 for Q1 2026 at Verastem, up from 0.23 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.63 in Q1 2022 to a low of 0.28 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.27 across 5 years, with a median of 0.27 in 2023.
  • The sharpest annual moves came in 2025 and 2026: Equity Ratio sank 221.39% in 2025, then soared 245.77% in 2026.
  • A 5-year view of Equity Ratio shows it stood at 0.5 in 2022, then dropped by 23.14% to 0.38 in 2023, then slumped by 174.25% to 0.28 in 2024, then soared by 181.56% to 0.23 in 2025, then soared by 54.67% to 0.36 in 2026.
  • The last three Equity Ratio figures came in at 0.36 (Q1 2026), 0.23 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 0.36

Historic Data

Download Data
DateValue
Mar 31, 2026 0.36
Dec 31, 2025 0.23
Sep 30, 2025 -0.09
Jun 30, 2025 0.18
Mar 31, 2025 -0.25
Dec 31, 2024 -0.28
Sep 30, 2024 0.09
Jun 30, 2024 0.18
Mar 31, 2024 0.20
Dec 31, 2023 0.38
Sep 30, 2023 0.47
Jun 30, 2023 0.53
Mar 31, 2023 0.27
Dec 31, 2022 0.50
Sep 30, 2022 0.57
Jun 30, 2022 0.54
Mar 31, 2022 0.63
Dec 31, 2021 0.81
Sep 30, 2021 0.86
Jun 30, 2021 0.71